Your browser doesn't support javascript.
loading
Role of interim PET/CT as predictor of outcome in newly diagnosed diffuse large b-cell lymphoma in the chemo-immunotherapy era.
Damlaj, Moussab; Jaber, Waed; Al Najjar, Afnan; Altamimi, Sumayyah; Al Onazi, Tarfa; Alzayed, Mohammed; Damlaj, Ahmad; Yassin, Rehab; Alahmari, Bader; Alhejazi, Ayman; Gmati, Giamal; Abuelgasim, Khadega; Salama, Hind; Alaskar, Ahmed; Al Zahrani, Mohsen.
Afiliação
  • Damlaj M; Division of Hematology & Oncology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE; Khalifa University, College of Medicine, Abu Dhabi, UAE; Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA; King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA; King Abdullah Internat
  • Jaber W; Division of Hematology & Oncology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE.
  • Al Najjar A; Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA.
  • Altamimi S; Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA.
  • Al Onazi T; Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA.
  • Alzayed M; King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA; King Abdullah International Medical Research Center, Riyadh, KSA; Department of Medical Imaging, King Abdulaziz Medical City, Riyadh, KSA.
  • Damlaj A; American University of Beirut, Beirut, Lebanon.
  • Yassin R; Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA; King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA; King Abdullah International Medical Research Center, Riyadh, KSA.
  • Alahmari B; Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA; King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA; King Abdullah International Medical Research Center, Riyadh, KSA.
  • Alhejazi A; Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA; King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA; King Abdullah International Medical Research Center, Riyadh, KSA.
  • Gmati G; Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA; King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA; King Abdullah International Medical Research Center, Riyadh, KSA.
  • Abuelgasim K; Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA; King Abdullah International Medical Research Center, Riyadh, KSA; Department of Medical Imaging, King Abdulaziz Medical City, Riyadh, KSA.
  • Salama H; Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA; King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA; King Abdullah International Medical Research Center, Riyadh, KSA.
  • Alaskar A; Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA; King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA; King Abdullah International Medical Research Center, Riyadh, KSA.
  • Al Zahrani M; Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA; King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA; King Abdullah International Medical Research Center, Riyadh, KSA.
Curr Res Transl Med ; 71(3): 103406, 2023.
Article em En | MEDLINE | ID: mdl-37542921
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Curr Res Transl Med Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Curr Res Transl Med Ano de publicação: 2023 Tipo de documento: Article